Literature DB >> 22977463

Induced pluripotent stem cell technology and stem cell therapy for diabetes.

Robert J Drummond1, Tilo Kunath, P Joseph Mee, James A Ross.   

Abstract

Although diabetes can be managed clinically with the use of insulin injections, it remains an incurable and inconvenient disorder. In the long-term, it is associated with a number of clinical complications, such as cardiovascular disease, resulting in a desire for the development of new methodologies to replace defective cells and provide a lasting normality without the need for drug treatment. Stem cells, including induced pluripotent stem cells, offer the possibility of generating cells suitable for transplantation due to their capacity to differentiate into all tissue lineages. However, many issues must be addressed before this type of treatment becomes a reality, including the need for a greater understanding of the underlying biology involved in the onset of diabetes.

Entities:  

Year:  2010        PMID: 22977463      PMCID: PMC3440679          DOI: 10.3892/etm.2010.173

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  44 in total

1.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

2.  Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

Authors:  N Lumelsky; O Blondel; P Laeng; I Velasco; R Ravin; R McKay
Journal:  Science       Date:  2001-04-26       Impact factor: 47.728

3.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.

Authors:  Wenlin Li; Wei Wei; Saiyong Zhu; Jinliang Zhu; Yan Shi; Tongxiang Lin; Ergeng Hao; Alberto Hayek; Hongkui Deng; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-12-18       Impact factor: 24.633

4.  Viable offspring derived from fetal and adult mammalian cells.

Authors:  I Wilmut; A E Schnieke; J McWhir; A J Kind; K H Campbell
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

5.  Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells.

Authors:  Micha Drukker; Helena Katchman; Gil Katz; Smadar Even-Tov Friedman; Elias Shezen; Eran Hornstein; Ofer Mandelboim; Yair Reisner; Nissim Benvenisty
Journal:  Stem Cells       Date:  2005-08-18       Impact factor: 6.277

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells.

Authors:  Maty Tzukerman; Tzur Rosenberg; Yael Ravel; Irena Reiter; Raymond Coleman; Karl Skorecki
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

8.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

10.  The first half-century of nuclear transplantation.

Authors:  J B Gurdon; J A Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-23       Impact factor: 12.779

View more
  2 in total

1.  MiRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells.

Authors:  Reyhaneh Lahmy; Masoud Soleimani; Mohammad H Sanati; Mehrdad Behmanesh; Fatemeh Kouhkan; Naser Mobarra
Journal:  Mol Biol Rep       Date:  2014-01-29       Impact factor: 2.316

2.  Genetic stability of pluripotent stem cells during anti-cancer therapies.

Authors:  Wiktoria Maria Suchorska; Ewelina Augustyniak; Magdalena Łukjanow
Journal:  Exp Ther Med       Date:  2016-01-13       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.